The Green Peak

Richard Zwicky discusses Decarbonization and Carbon Negative Production of Advanced Carbon Materials with Zachary Scott, the CEO of Green Carbon.

GreenCarbon is a breakthrough decarbonization company, specializing in the world’s first scalable and carbon negative production of Advanced Carbon Materials (ACM).

GreenCarbon provides an alternative and sustainable method of creating high-value, cost-effective, materials from various agricultural waste streams, rich in photosynthesized carbon, reducing the concentration of carbon dioxide in our atmosphere. 

GreenCarbon reduces industrial input costs and eliminates dependencies on transcontinental imports by sourcing waste domestically, enabling the continued reduction of emissions for millennia.

Andrew DeAngelo joins the Green Peak to follow-up after the Psychedelic Science Conference where scientists and activists convened at a massive conference in Denver back in June to declare a renaissance for drugs like psilocybin and MDMA.

We also discuss the predictions he penned in a Rolling Stone article that gave his 2023 Cannabis And Psychedelic Forecast.

Richard Zwicky and Stephen Murphy are discussing Cannabis Europa, the ninth edition of Prohibition Partners’ cannabis conference, which is held in the Barbecue venue in London. This year, the show has more North American audiences, including US companies, investors, producers, and ancillary companies. 

This year, Germany also announced its policy towards legalization for adult use, even though it is more of a decriminalization than actual legalization. The conference is a great opportunity for those interested in the cannabis industry to learn about the latest developments, as well as to enjoy the vibrant atmosphere the Barbecue venue offers.

They discussed two great shows coming up, and the 8th annual European Cannabis Report was recently published. This report explores the trends happening in each market, issues with the supply chain, and major regulatory reform for both medical and adult use. The report also highlights the growth of medical cannabis in Europe, as well as minor tweaks happening in mature markets that have a greater effect. Ultimately, the report shows that there is no one size fits all policy in cannabis, as each market has its own regulations and procedures.

NewLake Capital with CEOAnthony Coniglio today on The Green Peak with Richard Zwicky only on Cannabis Radio. Mr. Coniglio is CEO and a member of our board of directors. 

He co-founded NewLake in 2019 and continues to serve as Chief Executive Officer following the merger with GreenAcreage in March 2021. Prior to co-founding NewLake, Mr. Coniglio was the Chief Executive Officer of Primary Capital Mortgage (PCM), a residential mortgage company. 

Prior to PCM, he was a Managing Director at JPMorgan, leading various businesses, including a start-up platform, to leadership positions and helping grow business line profitability exponentially. 

During his 14 years at JPMorgan, Anthony was named by Dealmaker Magazine as “Top 40 under 40 on Wall Street” and led complex transactions, such as the financial-crisis restructurings for GMAC and Chrysler Financial, as well as AmeriCredit’s $3.5 billion sales to General Motors. Mr. Coniglio has led numerous initial public offerings for REITs and corporations, including MasterCard’s $5.3 billion initial public offerings.

More than 1.7 billion people around the world are unbanked and can’t access the financial services they need. Kiva is an international nonprofit, founded in 2005 in San Francisco, with a mission to expand financial access to help underserved communities thrive.

KIVA does this by crowdfunding loans and unlocking capital for the underserved, improving the quality and cost of financial services, and addressing the underlying barriers to financial access around the world. Through Kiva's work, students can pay for tuition, women can start businesses, farmers are able to invest in equipment and families can afford needed emergency care.

They believe lending alongside thousands of others is one of the most powerful and sustainable ways to create economic and social good. Lending on Kiva creates a partnership of mutual dignity and makes it easy to touch more lives with the same dollar. Fund a loan, get repaid and fund another.

Purissima is revolutionizing the way companies source and use plant-based ingredients, through the development and production of commercially viable, microbial biotechnology. Purissima's mission is to provide the world access to high-quality, pure, safe, and sustainable ingredients for products that improve the quality of life for millions. 

Purissima has sustainably and effectively recreated 60+ natural ingredients, including those rare or hard to access, at a fraction of the cost and without adverse environmental, varietal, or supply chain impact. The brand's patented and proprietary biotechnology advances critical plant-derived health + wellness solutions while preserving Earth's biodiversity and natural resources.

The Association for Cannabis Health Equity & Medicine (ACHEM [ay-kem]) is a mutual benefit, professional medical association for BIPOC healthcare professionals and students active or interested in cannabis science, cannabinoid medicine, and health equity. The Association for Cannabis Health Equity and Medicine (ACHEM) is a professional medical association within the Cannabis Health Equity Movement (CHEM)™. It is a mutual-benefit nonprofit organization serving the needs of BIPOC healers and health and medical professionals in the advancement of health equity and was founded by Drs. Janice, Jessica, and Rachel Knox, and Dr. Ogadinma "Oga" Obie.​

Travis has over 13 years of experience in commercial real estate investing across the capital stack, including debt and equity investments. At Pelorus, he sits on the credit committee and is responsible for the origination of new loans and new equity/debt investments.

In the sometimes-choppy waters of real estate, Pelorus Equity Group provides financing to keep property owners on course for their investment objectives, when traditional providers are unable or unwilling to help. 

They are experts in the rapidly growing cannabis build-out sub-sector, where demand for financing capital far outstrips supply, and many traditional lenders are unable to act efficiently or lend the required amounts necessary to complete tenant improvements. Through their real estate loans, they are able to provide income to their investors through the Pelorus Fund, their tax-advantaged Real Estate Investment Trust (REIT).

Mark Sims is the President and Chief Executive Officer of RIV Capital. Prior to joining RIV Capital, Mark served as Senior Vice President, Strategy and M&A at The Scotts Miracle-Gro Company, one of the world’s leading marketers of branded consumer lawn and garden as well as hydroponic and indoor growing products. In this role, he was responsible for leading the corporate strategy department which provides comprehensive strategy support for strategic intelligence, mergers and acquisitions, strategic planning, and internal consulting. 

He began his career with Scotts in 2007 and has held positions of increasing responsibility in strategy, M&A, enterprise risk management, process transformation, and IT; including serving as the CIO. Prior to joining Scotts Miracle-Gro, Mark spent 15 years in management consulting focused on business transformation to drive growth and productivity.

Mark serves on the Board of Directors of the regional health insurance company SummaCare and the Audit and Compliance Committee of their parent Summa Health. He completed the Advanced Management Program at the Wharton School, has a master’s in Industrial Engineering from Cleveland State University, and a bachelor’s in Industrial and Operations Engineering from the University of Michigan.

Allied Corp.'s mission is to help people around the world by creating and providing targeted cannabinoid health solutions. They use a scientific approach to make this mission possible, through cutting-edge pharmaceutical R&D, innovative plant-based production, and unique development of therapeutic products. Calum Hughes spent over a decade in hospital and clinical settings working as a clinician, teaching at the university level, and creating software that enabled legal cannabis producers in Canada to manage quality assurance audits.

Along the way, he got to know what was working and what wasn’t when it comes to high-quality premium cannabis production. Calum knew he needed to do something meaningful and helpful with all that experience and knowledge.

He also brings a deep passion to help people struggling with mental health issues. The same holds true for the rest of our team. They share that passion while representing the very best across a diverse range of sectors: medicine, pharmaceuticals, cannabis R&D, Post Traumatic Stress Injury (PTSI), innovative production, product development, and sustainable business growth.